Curing breast cancer and killing the heart: A novel model to explain elevated cardiovascular disease and mortality risk among women with early stage breast cancer.

Abstract:

:Due to advances in prevention, early detection and treatment, early breast cancer mortality has decreased by nearly 40% during the last four decades. Yet, the risk of cardiovascular disease (CVD) mortality is significantly elevated following a breast cancer diagnosis, and it is a leading cause of death in this population. This review will discuss the most recent evidence for risks, pathology, mechanisms, and prevention of CVD morbidity and mortality in women with breast cancer. This evidence will be synthesized into a new model 'the compounding risk and protection model.' This model proposes that the balance between risk factors (i.e., older age, pre-existing traditional CVD risk factors and shared biologic pathways for CVD and cancer such as inflammation, as well as treatment-related and lifestyle toxicity) and potential protection factors (i.e., lifelong non-smoking, regular physical activity, a healthy diet rich in fruits and vegetables, and management of body weight and stress, heart failure therapy) determine the individual risk of CVD morbidity and mortality after diagnosis of early breast cancer.

journal_name

Prog Cardiovasc Dis

authors

Kirkham AA,Beaudry RI,Paterson DI,Mackey JR,Haykowsky MJ

doi

10.1016/j.pcad.2019.02.002

subject

Has Abstract

pub_date

2019-01-01 00:00:00

pages

116-126

issue

2

eissn

0033-0620

issn

1873-1740

pii

S0033-0620(19)30034-9

journal_volume

62

pub_type

杂志文章,评审
  • The use of echocardiography for quantitative evaluation of left ventricular function.

    abstract::Echocardiography is a valuable technique for the diagnosis and serial follow-up of patients with impaired cardiac function. It is subject to certain limitations due to the assumptions inherent in deriving ventricular volume from a one-dimensional measurement and must be interpreted with caution in cases of suspected r...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(78)90018-x

    authors: Mason SJ,Fortuin NJ

    更新日期:1978-09-01 00:00:00

  • The economics of smoking and cardiovascular disease.

    abstract::The direct medical cost of cardiovascular and circulatory diseases was $151 billion in 1995, approximately 17% of all direct medical care costs in the United States. Incidence and prevalence based estimates indicate that smoking is a major contributing factor for cardiovascular disease and associated costs. Statewide ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(03)00077-x

    authors: Lightwood J

    更新日期:2003-07-01 00:00:00

  • How much should LDL cholesterol be lowered in secondary prevention? Clinical efficacy and safety in the era of PCSK9 inhibitors.

    abstract::There is a strong evidence that more marked lowering of low-density lipoprotein cholesterol (LDL-C) leads to progressively lower risk of cardiovascular disease (CVD) events. The evidence on validity of this hypothesis comes from epidemiological, genetic and clinical studies. The hypothesis "the lower the better" has b...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2020.12.008

    authors: Cybulska B,Kłosiewicz-Latoszek L,Penson PE,Nabavi SM,Lavie CJ,Banach M,International Lipid Expert Panel (ILEP).

    更新日期:2020-12-28 00:00:00

  • Systemic and local inflammation in patients with unstable atherosclerotic plaques.

    abstract::The response to injury in the vasculature and the heart is inflammation. Atherosclerosis is often the result of injury followed by inflammation and atherosclerosis. Vascular and myocardial infections from various pathogens, including viruses, bacteria, chlamydia, and other infections result in vascular inflammation an...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2002.123782

    authors: Willerson JT

    更新日期:2002-05-01 00:00:00

  • The cellular ionic basis of hypertension and allied clinical conditions.

    abstract::Two central concepts of human hypertensive disease remain poorly understood: (1) elevated blood pressure as merely one component of an underlying systemic condition, characterized by multiple defects in diverse tissues (eg, "Syndrome X"), and (2) the heterogeneity of hypertension, in which different and even opposite ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(99)70006-x

    authors: Resnick L

    更新日期:1999-07-01 00:00:00

  • Electrophysiology and adult congenital heart disease: advances and options.

    abstract::Although "congenital heart disease" incorporates a broad and diverse spectrum of inborn cardiac disorders, one shared feature is the propensity for cardiac arrhythmias, albeit to varying degrees. The magnitude of this issue is underscored by its high prevalence, major impact on morbidity and disability, considerable c...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2010.07.003

    authors: Abadir S,Khairy P

    更新日期:2011-01-01 00:00:00

  • Thyroid hormone therapy in cardiovascular disease.

    abstract::The relationship between thyroid disease states and cardiovascular hemodynamics is well recognized. Although the long-term effects of thyroid hormone are thought to result from changes in myocardial gene expression, attention has recently focused on acute, non-nuclear-mediated actions of L-triidothyronine (T3), the bi...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(96)80017-x

    authors: Klemperer JD,Ojamaa K,Klein I

    更新日期:1996-01-01 00:00:00

  • New Concepts in Hypertension Management: A Population-Based Perspective.

    abstract::Hypertension (HTN) is the most common chronic disease in the U.S., and the standard model of office-based care delivery has yielded suboptimal outcomes, with approximately 50% of affected patients not achieving blood pressure (BP) control. Poor population-level BP control has been primarily attributed to therapeutic i...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2016.09.005

    authors: Milani RV,Lavie CJ,Wilt JK,Bober RM,Ventura HO

    更新日期:2016-01-01 00:00:00

  • Cardiovascular adjustments to exercise: hemodynamics and mechanisms.

    abstract::The integrated response to severe exercise involves fourfold to fivefold increases in cardiac output, which are due primarily to increases in cardiac rate and to a lesser extent to augmentation of stroke volume. The increase in stroke volume is partly due to an increase in end-diastolic cardiac size (Frank-Starling me...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(76)90018-9

    authors: Vatner SF,Pagani M

    更新日期:1976-09-01 00:00:00

  • Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.

    abstract::Because not all laboratories use the monitoring and stimulation protocols used in the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) trial, we reanalyzed the ESVEM patients' data using alternative, commonly used Holter monitor (HM) and programmed stimulation efficacy criteria to determine if d...

    journal_title:Progress in cardiovascular diseases

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1016/s0033-0620(96)80029-6

    authors: Reiffel JA,Reiter MJ,Freedman RA,Mann D,Huang SK,Hahn E,Hartz V,Mason J,ESVEM Investigators.

    更新日期:1996-03-01 00:00:00

  • In Defense of Sugar: A Critique of Diet-Centrism.

    abstract::Sugars are foundational to biological life and played essential roles in human evolution and dietary patterns for most of recorded history. The simple sugar glucose is so central to human health that it is one of the World Health Organization's Essential Medicines. Given these facts, it defies both logic and a large b...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.04.007

    authors: Archer E

    更新日期:2018-01-01 00:00:00

  • Diagnosis and treatment of high density lipoprotein deficiency.

    abstract::Low serum high density lipoprotein cholesterol level (HDL-C) <40 mg/dL in men and <50 mg/dL in women is a significant independent risk factor for cardiovascular disease (CVD), and is often observed in patients with hypertriglyceridemia, obesity, insulin resistance, and diabetes. Patients with marked deficiency of HDL-...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2016.08.006

    authors: Schaefer EJ,Anthanont P,Diffenderfer MR,Polisecki E,Asztalos BF

    更新日期:2016-01-01 00:00:00

  • Mechanisms of tissue injury in renal artery stenosis: ischemia and beyond.

    abstract::Renal injury distal to an atherosclerotic renovascular obstruction reflects multiple intrinsic factors producing parenchymal tissue injury. Atherosclerotic disease pathways superimposed on renal arterial obstruction may aggravate damage to the kidney and other target organs, and some of the factors activated by renal ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2009.09.002

    authors: Lerman LO,Textor SC,Grande JP

    更新日期:2009-11-01 00:00:00

  • Transcatheter Valve Replacement for Right-sided Valve Disease in Congenital Heart Patients.

    abstract::Pulmonary and/or tricuspid valve dysfunction is common among individuals with congenital heart disease, and surgical intervention often carries prohibitive risks. Transcatheter valve replacement (TVR) of the right-sided cardiac valves has become a viable treatment option over the past two decades, while continued tech...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.09.003

    authors: Gales J,Krasuski RA,Fleming GA

    更新日期:2018-01-01 00:00:00

  • Telemedicine and advances in urban and rural healthcare delivery in Africa.

    abstract::Telecardiology holds great promise for Africa, from tele-echocardiography and tele-ECG s, to home monitoring and text messaging for medication adherence monitoring. The burden of disease is great and there is an extreme shortage of health professionals. Telemedicine can provide access to scarce specialist care, improv...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2013.10.006

    authors: Mars M

    更新日期:2013-11-01 00:00:00

  • Obesity and Kidney Disease.

    abstract::Obesity is a systemic disease of the white adipose tissue, which has evolved into a global epidemic. It is associated with a plethora of adipocyte hormonal (adipokine) imbalances, dysregulation of the energy-balance system, imbalances in metabolic homeostasis, a pro-inflammatory state and multiple target organ damages...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.07.005

    authors: Lakkis JI,Weir MR

    更新日期:2018-01-01 00:00:00

  • Nonvascular stents.

    abstract::Stents or endoprostheses have evolved since their introduction. Initially used only in the vascular system, the use of stents has expanded to use in the biliary, urinary, and gastrointestinal tracts and in the tracheo-bronchial tree. Current use of stents includes treatment of both benign and malignant conditions, wit...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(96)80025-9

    authors: Vanderburgh L,Ho CS

    更新日期:1996-09-01 00:00:00

  • Secondary analysis of clinical trials--a cautionary note.

    abstract::There is concern in published reports and reviews that patients are being harmed or denied effective treatment by the use of questionable results from secondary analyses of data from clinical trials. A well-reported secondary analysis must make clear to the reader the uncertainty of the result--so clear, in fact, that...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2011.09.006

    authors: Marler JR

    更新日期:2012-01-01 00:00:00

  • HIV Infection and Primary Prevention of Cardiovascular Disease: Lights and Shadows in the HAART Era.

    abstract::With the progressive increase in life-expectancy of human immunodeficiency virus (HIV)-positive patients in the "highly active antiretroviral therapy" (HAART) era, co-morbidities, particularly cardiovascular (CV) diseases (CVD) are emerging as an important concern. The pathophysiology of CVD in this population is comp...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2016.02.008

    authors: Ballocca F,Gili S,D'Ascenzo F,Marra WG,Cannillo M,Calcagno A,Bonora S,Flammer A,Coppola J,Moretti C,Gaita F

    更新日期:2016-03-01 00:00:00

  • Exercise in valvular heart disease: risks and benefits.

    abstract::Valvular heart disease (VHD) carries documented risks for active individuals. At the same time, many individuals with intermediate degrees of valve disease can safely exercise and even participate in competitive athletics. Unfortunately for clinicians caring for these patients, data are scarce. Understanding the patho...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2011.02.010

    authors: Parker MW,Thompson PD

    更新日期:2011-05-01 00:00:00

  • Percutaneous Treatment for Native Mitral Regurgitation.

    abstract::Severe mitral regurgitation (MR) confers an adverse prognosis, frequently with debilitating symptoms of heart failure. While open surgical correction has been the standard of care for decades, novel catheter-based technologies have emerged that are highly effective in the treatment of MR. These percutaneous technologi...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.11.003

    authors: Sorajja P,Maisano F

    更新日期:2017-01-01 00:00:00

  • Are the neuroprotective effects of exercise training systemically mediated?

    abstract::To date there is no cure available for dementia, and the field calls for novel therapeutic targets. A rapidly growing body of literature suggests that regular endurance training and high cardiorespiratory fitness attenuate cognitive impairment and reduce dementia risk. Such benefits have recently been linked to system...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2019.02.003

    authors: Tari AR,Norevik CS,Scrimgeour NR,Kobro-Flatmoen A,Storm-Mathisen J,Bergersen LH,Wrann CD,Selbæk G,Kivipelto M,Moreira JBN,Wisløff U

    更新日期:2019-01-01 00:00:00

  • Outcomes in Degenerative Mitral Regurgitation: Current State-of-the Art and Future Directions.

    abstract::Mitral regurgitation (MR) is the one of the most frequent valvular heart diseases in the developed world, often requiring surgical correction. Degenerative MR is the most common type of non-ischemic, organic MR in the western world. Since no medical treatment has been shown to be effective in preventing the consequenc...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2017.10.005

    authors: Desai MY,Grigioni F,Di Eusanio M,Saccocci M,Taramasso M,Maisano F,Suri RM,Gillinov AM

    更新日期:2017-01-01 00:00:00

  • Hypertrophic cardiomyopathy--therapy with slow channel inhibiting agents.

    abstract::Slow channel inhibiting agents, particularly verapamil, appear to produce beneficial effects in relieving symptoms of dyspnea, chest pain, and syncope or presyncope in over 70% of patients with hypertrophic cardiomyopathy. Symptomatic relief occurs in patients with and without left ventricular outflow obstruction. Exe...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/0033-0620(82)90016-0

    authors: Chatterjee K,Raff G,Anderson D,Parmley WW

    更新日期:1982-11-01 00:00:00

  • Triple Antithrombotic Therapy for Patients with Atrial Fibrillation Undergoing Percutaneous Coronary Intervention.

    abstract::Dual antiplatelet therapy (DAPT) has been the cornerstone of antithrombotic management for patients undergoing percutaneous coronary intervention (PCI). However, approximately 10% of these patients have concomitant atrial fibrillation (AF) and require chronic oral anticoagulant (OAC) in addition to DAPT. This traditio...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2018.01.008

    authors: Kerneis M,Talib U,Nafee T,Daaboul Y,Pahlavani S,Pitliya A,Furqan MM,Datta S,Kazmi HA,Younes A,Gibson CM

    更新日期:2018-01-01 00:00:00

  • Positron-emitting myocardial blood flow tracers and clinical potential.

    abstract::Positron-emitting myocardial flow radiotracers such as (15)O-water, (13)N-ammonia and (82)Rubidium in conjunction with positron-emission-tomography (PET) are increasingly applied in clinical routine for coronary artery disease (CAD) detection, yielding high diagnostic accuracy, while providing valuable information on ...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/j.pcad.2015.01.001

    authors: Schindler TH

    更新日期:2015-05-01 00:00:00

  • Electrophysiological basis of QT dispersion measurements.

    abstract::Dispersion of ventricular repolarization is a now widely used term describing nonhomogeneous recovery of excitability or heterogeneity of ventricular repolarization. It is usually expressed as the difference or the range of various repolarization measurements obtained from a heart. Experimentally, an increased dispers...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.2000.0420311

    authors: Franz MR,Zabel M

    更新日期:2000-03-01 00:00:00

  • Cardiovascular morbidity in obstructive sleep apnea.

    abstract::The repetitive respiratory events that characterize obstructive sleep apnea (OSA) are each followed by abrupt increases in heart rate and in pulmonary and systemic artery pressure and by sudden decreases in right and left ventricular stroke volume. The changes in systemic pressure may be profound, with patients who ar...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1053/pcad.1999.0410367

    authors: Weiss JW,Launois SH,Anand A,Garpestad E

    更新日期:1999-03-01 00:00:00

  • Cardiac endothelium and tissue growth.

    abstract::In recent years, a number of peptide and nonpeptide signalling autacoids have been implicated in the regulation of cardiac myocyte growth as well as vasculogenesis and angiogenesis, and in the function of cardiac muscle following development. In this review, we first examine the evidence for a role for specific cytoki...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(97)80033-3

    authors: Balligand JL,Kelly RA,Smith TW

    更新日期:1997-01-01 00:00:00

  • Optimal use of coronary care units: a review.

    abstract::Patients at a low probability of acute cardiac pathology constitute a considerable proportion in many coronary care units (CCUs), such that physicians should consider more effective alternatives than CCU admission "to rule out myocardial infarction." In this article, strategies to increase the efficiency of managing p...

    journal_title:Progress in cardiovascular diseases

    pub_type: 杂志文章,评审

    doi:10.1016/s0033-0620(05)80021-0

    authors: Grijseels EW,Deckers JW,Hoes AW,Hartman JA,van der Does E,Simoons ML

    更新日期:1995-05-01 00:00:00